Ahlskog JE. Does vigorous exercise have a neuroprotective effect in Parkinson’s disease? Neurology. 2011;77:288-294.
Alberts JL. Linder SM. Penko AL. Lowe MJ. Phillips M. It is not about the bike, it is about the pedaling: forced exercise and Parkinson’s disease. Exerc Sport Sci Rev. 2011;39:177–186.
Allen NE, Sherrington C, Suriyarachchi, GD, Paul SS, Song J, Canning CG. Exercise and motor training in people with Parkinson’s disease: a systematic review of participant characteristics, intervention delivery, retention rates, adherence, and adverse events in clinical trials. Parkinson’s disease. 2012;1-15.
Archer T, Fredriksson A, Johansson B. Exercise alleviates Parkinsonsim: clinical and laboratory evidence. Acta Neruol Scand. 2011; 123:73-84.
Bhidayasiri R, Tarsy D. Parkinson’s disease: “On-Off” phenomenon. In: Movement Disorders: Current Clinical Neurology. Humana Press, NY; 2012:14-15.
Borghammer P. How does Parkinson’s Disease begin? Perspectives on neuroanatomical pathways, prions, and histology. Move Disord. 2018:33(1):48-57.
Braak H, Ghebremedhin RU, Bratske H, Tredici KD. Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res. 2004;318:121-134.
Brauer SG, Morris ME. Can people with Parkinson’s disease improve dual tasking when walking? Gait & Posture. 2010;31(2):229-233.
Cotman CW, Berchtold NC. Exercise: A behavioral intervention to enhance brain health and plasticity. Trends in Neuroscience. 2002;25(6):295-301.
Dibble LE, Addison O, Papa E. The effects of exercise on balance in persons with Parkinson’s disease: a systematic review across the disability spectrum. J Neurol Phys Ther. 2009;33:14-26.
Dibble LE, Hale TF, Marcus RL, Gerber JP, LaStayo PC. High intensity eccentric resistance training decreases bradykinesia and improves quality of life in persons with Parkinson’s disease: a preliminary study. Parkinsonism Relat Disord. 2009; 15(10):752-757.
Ebersbach G, Ebersbach A, Edler D, Kaufhold O, Musch M, Kupsch A, Wissel J. Comparing exercise in Parkinson’s disease- the Berlin LSVT BIG study. Movement Disorders. 2010;25(12):1902-1908.
Ellis T, Boudreau JK, DeAngelis T, Brown LE, Cavanaugh JT, Earhart GM, Ford MP, Foreman KB, Dibble LE. Barriers to exercise in people with Parkinson’s disease. Phys Ther. 2013;93(5):628-636.
Eriksson T, Magnusson T, Carlsson A, Linde A, Granerus AK. On-off phenomenon in Parkinson’s disease: correlation to the concentration of dopa in plasma. J Neural Trans. 1894;59(3):229-240.
Fisher BE. Li Q, Nacca A, Salem GJ, Song J, Yip J, Hui JS, Jakowec MW, Petzinger GM. Treadmill exercise elevates striatal dopamine D2 receptor binding potential in patients with early Parkinson’s disease. NeuroReport. 2013;24:509-514.
Frazzitta G, Balbi P, Maestri R, Bertotti G, Boveri N, Pezzoli G. The beneficial role of intensive exercise on Parkinson’s disease progression. Am J Phys Med Rehabil. 2013;92:523-532.
Gepshtein S, Li X, Snider J, Plank M, Lee D, Poizner H. Dopamine function and the efficiency of human movement. J Cogn Neurosci. 2014;26(3):645-657.
Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord. 2004;19(9):1020-1028.
Hawkes CH, Del Tredici K, Braak H. Parkinson’s Disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol. 2007;33(6):599-614.
Hirsch MA, Iyer SS, Sanjak M. Exercise-induced neuroplasticity in human Parkinson’s disease: What is the evidence telling us? Parkinsonism Rel Disord. 2016; 22:S78-S81.
Keus SH, Bloem BR, Hendriks EJ, Bredero-Cohen AB, Munneke M. Evidence based analysis of physical therapy in Parkinson’s disease with recommendations for practice and research. Movement disorders. 2007;22(4):451-460.
King LA, Priest KC, Salarian A, Pierce D, Horak KB. Comparing the mini-BESTest with the Berg Balance Scale to evaluate balance disorders in Parkinson’s disease. Parkinson’s disease. 2011; 11;1-7.
Kowal SL, Dall TM, Chakrabarti R, Storm MV, Jain A. The current and projected economic burden of Parkinson’s disease in the United States. Movement Disorders. 2013; 28(3):311-318.
Lima LO, Scianni A, Rodriges-de-Paula F. Progressive resistance exercise improves strength and physical performance in people with mild to moderate Parkinson’s disease: a systematic review. J Physiotherapy. 2013;59:7-13.
Marusiak J, Zeligoska E, Mencel J, Kisiel-Sajewicz, Majerczak, Zoldaz, Jaskolski A, Jaskolska A. Interval training-induced alleviation of rigidity and hypertonia in patients with Parkinson’s disease is accompanied by increased basal serum brain-derived neurotrophic factor: a repeated measures, case series pilot study. J Rehabil Med. 2015;47(4):372-375.
Nieuwbore A, Kwakkel G, Rochester L, Jones D, van Wegen E, Willems AM, Chavret F, Hetherington V, Baker K, Lim I. Cuing training in the home improves gait-related mobility in Parkinson’s disease: the RESCUE trial. J Neurol Neurosurg Psychiatry. 2007;78:134-140.
Park A, Zid D, Russell J, Malone A, Rendon A, Wehr A. Effects of a formal exercise program on Parkin- son’s disease: A pilot study using a delayed start design. Parkinsonism and Related Disorders. 2013;article in press.
Petzinger GM, Fisher BE, McEwen S, Beeler JA, Walsh JP, Jakowec MW. Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson’s disease. Lancet Neurol. 2013;12:716-726.
Petzinger GM, Fisher BE, Van Leeuwen JE, Vukovic M, Akopian G, Meshul CK, Holschneider DP, Nacca A, Walsh JP, Jakowec MW. Enhancing neuroplasticity in the basal ganglia: The role of exercise in Parkinson’s disease. Movement Disorders. 2010; 25:S141-S145.
Petzinger GM, Holschneider DP, Fisher BE, McEwen S, Kintz N, Halliday M, Toy W, Walsh JW, Beeler J, Jakowec MW. The effects of exercise on dopamine neurotransmission in Parkinson’s Disease: targeting neuroplasticity to module Basal Ganglia circuitry. Brain Plast. 2015; 1(1):29-39.
Sehm B, Taubert M, Conde V, Weise D, Classen J, Dukart J, Draganski B, Villringer A, Ragert P. Structural brain plasticity in Parkinson’s disease induced by balance training. Neurobiol aging. 2014;35:232-239.
Siegert RJ, Weatherall M, Taylor KD, Abernethy DA. A meta-analysis of performance on simple span and more complex working memory tasks in Parkinson’s disease. Neurophyschology. 2008;22(4):450-461.
Speelman AD, Groothuis JT, Nimwegen MV, van der scheer ES, Borm GF, Bloem B, Hopman MT, Munneke M. Cardiovascular responses during a submaximal exercise test in patients with Parkinson’s disease. Parkinson’s disease. 2012;2:241-247.
States RA, Spierer DK, Salem Y. Long-term group exercise for people with Parkinson’s Disease: a feasibility study. J Neuro Phys Ther. 2011;35:122-128.
Steffen T, Petersen C, Dvorak L. Community-based exercise and wellness program for people diagnosed with Parkinson’s disease: experiences from a 10-month trial. J Geriatr Phys Ther. 2012; 35:173-180.
Srouwen C, Molenaar EA, Munks L, Keus, Nieuwboer A. Training dual tasks together or apart in Parkinson’s Disease: Results from the DUALITY trial. Mov Disord. 2017:32(8):1201-1210.
Tillerson JL, Reveron ME, Miller GW. Exercise induces behavioral recovery and attenuates neurochemical deficits in rodent models of Parkinson’s disease. Neuroscience. 2003;119:899-911. Cochrane Database Syst Rev 2012; 8:1-101.
Tomlinson CL, Patel S, Meek C, Clarke CE, Stowe R, Shah L, Sackley CM, Deane KH, Herd CP, Wheatley K, Ives N. Physiotherapy versus placebo or no intervention in Parkinson’s disease. Cochrane Database Syst Rev. 2012;11(7):CD002817.
Willis AW, Evanoff BA, Lian M, Criswell SR, Racette BA. Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries. Neuroepidemiology. 2010;34:143-151.
Xu Q, Park Y, Huang X, et al. Physical activities and future risk of Parkinson disease. Neurol. 2010; 75:341-348.
Yin HH, Mulcare SP, Hilario MR, et al. Dynamic reorganization of striatal circuits during the acquisition and consolidation of a skill. Nat Neurosci. 2009;12:333-341.
Zoldaz JA, Majerczak J, Zeligowska E, Mencel K, Jaskolski A, Jaskolska, Marusiak J. Moderate-intensity interval training increases serum brain-derived neurotrophic factor level and decreases inflammation in Parkinson’s disease patients. J Physiol Pharmacol. 2014;65(3):441-448.